Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium;Inhibition der Reflux-induzierten Apoptose im Barrett-Epithel

Acta Chirurgica Austriaca

Volumn 31, Issue 6, 1999, Pages 362-364

  Wykypiel, H ^a   Gadenstatter M ^a   Wetscher, G ^a,b  

^a A K A f A C der U K f C   (Austria)

^b Universitatsklinik fur Chirurgie Innsbruck   (Austria)

Author keywords

Apoptosis; Barrett's esophagus; Gastroesophageal reflux disease

Indexed keywords

ANTIREFLUX OPERATION; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE SEVERITY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REFLUX ESOPHAGITIS; SQUAMOUS EPITHELIUM;

EID: 0342614272     PISSN: 0001544X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bagchi M, Hassoun EA, Bagchi D, Stohs SJ: Endrin-induced increases in hepatic lipid peroxidation, membrane microviscosity, and DNA damage in rats. Arch Environ Contam Toxicol 1992; 23: 1-5.
2. Clark GWB, Smyrk TC, Burdiles P: Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129: 609-614.
3. Cohen JJ: Overview: mechanismus of apoptosis. Immunol Today 1993; 14: 126-130.
4. Darzynkiewicz Z, Bruno S, Del Bino G: Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-808.
5. DeMeester TR, Wang CI, Wernly JA: Technique, indications and clinical use of 24-hour esophageal pH monitoring. J Thorac Cardiovasc Surg 1980; 79: 656-670.
6. Evan GI, Wyllie AH, Gilbert CS: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
7. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
8. Green DR, Martin SJ: The killer and the executioner: how apoptosis controls malignancy. Curr Opin Immunol 1995; 7: 694-703.
9. Haegele AD, Briggs SP, Thompson HJ: Antioxidant status and dietary lipid unsaturalion modulate oxidative DNA damage. Free Radic Biol Med 1994; 16: 111-115.
10. Harris CC, Hollstein M: Clinical implications of the p-53 tumor suppressor gene. N Engl J Med 1993; 329: 1318-1327.
11. Ireland AP, Clark GWB, DeMeester TR: Barret's esophagus: the significance of p53 in clinical practice. Ann Surg 1997; 225: 17-30.
12. Itoh N, Yonehara S, Ishii A: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
13. Katada N, Hinder RA, Smyrk TC: Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg 1997; 132: 728-733.
14. Locke GR, Talley NJ, Fett SL: Prevalence and clinical spectrum of gastro-esophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456.
15. Oehm A, Behrmann I, Falk W: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992; 267: 10709-10715.
16. Sakamuro D, Eviner V, Elliott KJ, et al.: Oncogene 11, 2411 (1995).
17. Savary M, Miller G: The Esophagus. Handbook and Atlas of Endoscopy. Solothurn, Switzerland, Gassmann AG, 1978, pp 135-139.
18. Seabrook M, Holt S, Gilrane T: Barret's esophagus: observations on diagnosis and management. Southern Med J 1992; 85: 280-288.
19. Shi Y. et al.: Science 1992; 257: 212.
20. Smyrk TC: Histology in the diagnosis of foregut disease. In Hinder RA, Nyhus DM (Eds): Problems in General surgery. Tests of the Foregul Function. Vol 9. Philadelphia, Lippincott, 1992, pp 14-38.
21. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 1986; 315: 362- 371.
22. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
23. Wetscher GJ, Glaser K, Gadenstätter M: Gastroesophageal reflux disease associated with poor esophageal body motility is effectively treated by laparoscopic Toupet fundoplication. Acta Chir Austriaca 1996; 28: 49-54.
24. Wetscher GJ, Glaser K, Wieschemeyer T: Tailored antireflux surgery in gastroesophageal reflux disease is effective and has a low risk of postoperative dysphagia. World J Surg 1997; 21: 605-610.
25. Wetscher GJ, Hinder PR, Baghi D: Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995; 40: 1292-1296.
26. Wetscher GJ, Hinder RA, Bagchi D: Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170: 552-557.
27. Wetscher GJ, Hinder RA, Klingler P: Reflux esophagitis in humans is a free radical event. Dis Esoph 1997; 10: 29-32.
28. Wetscher GJ, Hinder RA, Kretchmar D: Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996; 41: 2166-2173.
29. Wetscher GJ, Hinder RA, Perdikis G: Three-dimensional imaging of the lower esophageal sphincter in healthy subjects and gastroesophageal reflux. Dig Dis Sci 1996; 41: 2377-2382.
30. Wetscher GJ, Perdikis G, Kretchmar DH: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995; 1297-1305.